Tobaiqy Mansour, Stewart Derek, Helms Peter J, Bond Christine M, Lee Amanda Jane, McLay James
Division of Applied Health Sciences, The Aberdeen Medical School, The University of Aberdeen, Aberdeen, Scotland, UK.
Pharm World Sci. 2010 Jun;32(3):334-8. doi: 10.1007/s11096-010-9374-0. Epub 2010 Feb 25.
To explore the experiences and views of community pharmacists and parents participating in a prospective paediatric pharmacovigilance study.
Twenty-five pharmacists and 32 parents were approached for telephone interview. Interviews were audio-recorded, transcribed and analysed thematically to identify recurring issues and themes.
Seventeen pharmacists and 22 parents were interviewed. Parents and pharmacists agreed that more information about the side effects of medicines in children was required. Both groups reported willingness to participate in future prospective pharmacovigilance studies, although pharmacists expressed concerns about the lack of financial incentives. Pharmacists reported that parents had concerns regarding the confidentiality of their child's ADR data and the study data collection process.
This study highlighted positive and negative opinions of parents and pharmacists regarding their experiences in this research project. Maintaining confidentiality in relation to indication and medicines prescribed were important issues for parents whereas time constraints and lack of financial incentives were key issues influencing participation by community pharmacists.
探讨参与一项前瞻性儿科药物警戒研究的社区药剂师和家长的经历与观点。
联系了25名药剂师和32名家长进行电话访谈。访谈进行了录音、转录，并进行主题分析以识别反复出现的问题和主题。
采访了17名药剂师和22名家长。家长和药剂师一致认为需要更多关于儿童药物副作用的信息。两组都表示愿意参与未来的前瞻性药物警戒研究，尽管药剂师对缺乏经济激励表示担忧。药剂师报告称，家长对其孩子的药品不良反应数据及研究数据收集过程的保密性存在担忧。
本研究突出了家长和药剂师对其在该研究项目中的经历的积极和消极看法。对家长来说，保持与用药指征和所开药物相关的保密性是重要问题，而时间限制和缺乏经济激励是影响社区药剂师参与的关键问题。
